Larvol Delta - BioCardia-Announces-Positive-DSMB-Review-of-CardiALLO-Allogeneic-Cell-Therapy-for-Heart-Failure-Phase-12-Clinical-Trial

CardiALLO (BCDA-03) - BioCardia

https://www.globenewswire.com/news-release/2025/04/15/3061732/0/en/BioCardia-Announces-Positive-DSMB-Review-of-CardiALLO-Allogeneic-Cell-Therapy-for-Heart-Failure-Phase-1-2-Clinical-Trial.html

Apr 15, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next